19th Annual Superbugs & Superdrugs
20 March 2017 - 21 March 2017
SMi’s flagship show in its global Superbugs portfolio of events has been expanding horizons on the growing threat of anti-microbial resistance (AMR) and infectious disease for almost two decades. Now in its 19th year, Superbugs & Superdrugs returns to London on 20th and 21st March 2017, providing a focal point for its growing “superbugs” community to exchange novel solutions and consolidate current strategies. Hear from panel of speakers who will hone in on key issues such as funding, animal models in drug research and antimicrobial peptides. Highlights include an exclusive keynote address from the FDA.
Featured Speakers:
• Sumathi Nambiar, Director, Division of Anti-Infective Products, FDA
• Richard Bax, Senior Partner, TranScrip
• Lloyd Czaplewski, Director, Chemical Biology Ventures
• Chris Houchens, Branch Chief, BARDA
• James Anderson, Head of Corporate Government Affairs, GlaxoSmithKline
• Aileen Rubio, Head of Biology, Spero Therapeutics
• David Williams, Chief Executive Officer, Discuva
• Martin Everett, Chief Scientific Officer, ANTABIO SAS
• Jean de Gunzburg, Scientific Director, Da Volterra
• William J Weiss, Director, Pre-Clinical Services, UNT System College of Pharmacy
Copthorne Tara Hotel, Kensington, London UK
https://www.smi-online.co.uk/pharmaceuticals/uk/superbugs-superdrugs?utm_medium=www.superbugssuperdrugs.com&utm_source=P-198&utm_campaign=ddt
9th Ocular Diseases Drug Discovery Conference
20 March 2017 - 21 March 2017
The 9th Ocular Diseases Drug Discovery Conference is taking place on March 20-21, 2017 in San Diego, CA. We are excited to have top representatives from the industry and academic sectors to discuss technologies and targets that are continually changing the way ocular diseases are treated. Drug delivery is always improving as we look at for better methods to penetrate anterior and poster segments of the eye. Successes in gene therapy and regenerative medicine are proving to be interesting approaches to discuss in detail pre-clinically and clinically. We are gathering leading scientists, researchers, and experts to discuss and collaborate on combating and curing age-related macular degeneration (AMD), dry eye, glaucoma, diabetic macular edema (DME), and other ocular diseases.
Hilton San Diego Resort and Spa, San Diego, CA, USA
https://www.gtcbio.com/conferences/ocular-diseases-drug-discovery-overview
Biomarker Summit 2017
20 March 2017 - 22 March 2017
The Biomarker Summit 2017, to be held on March 20-22, 2017 in San Diego, CA at the Hilton San Diego Resort & Spa, is a meeting place for leaders in the field to discuss the issues and challenges scientists and researchers face in all aspects of the biomarker and diagnostic development process from discovery to translation to commercialization.
A wide variety of important topics will be covered including biomarker identification, validation, and translation strategies, bioinformatics and systems biology approaches to personalized medicine, big data analytics and management, regulatory and reimbursement trends, companion diagnostics development, and much more. Through scientific presentations, case studies and panel discussions, these areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector.
Assembling leading scientists, researchers, decision-makers and other players across the industry spectrum, the Summit provides a unique opportunity to gain the latest biomarker developments in four major therapeutic areas, formally organized in the following tracks:
San Diego Resort and Spa, San Diego, CA, USA
https://www.gtcbio.com/conferences/biomarkers-summit-overview
10th Oncology Biomarkers Conference
20 March 2017 - 22 March 2017
The 10th Oncology Biomarkers Conference is one of four conferences part of the Biomarker Summit 2017 to be held on March 20-22, 2017 in San Diego, CA. This conference brings together experts in industry, academia and government to discuss the latest developments in the oncology biomarker research arena. Hot topics include circulating tumor cells, cell free DNA, digital pathology and imaging biomarkers. Applications of technologies such as mass spectrometry and next generation sequencing as well as data analysis and interpretation will also be discussed.
Please join us for the opportunity to listen to recent updates on research, share ideas with colleagues, and network with experts to advance biomarker discovery and development.
Hilton San Diego Resort and Spa, San Diego, CA, USA
https://www.gtcbio.com/conferences/oncology-biomarkers-overview
BIT's 10th Anniversary of Protein & Peptide Conference, PepCon-2017
22 March 2017 - 24 March 2017
To celebrate BIT's 10th Anniversary of Protein & Peptide Conference, PepCon-2017 will be held during March 22-24, 2017, in Fukuoka, Japan. With 9 years’ conference holding experiences support, as well as variety social events, the PepCon-2017 will attract 400+ Participants from 20+ Countries with 100+ Poster and Exhibition Presentations to join in the grand festival!
Hilton Fukuoka Sea Hawk, Fukuoka, Japan
http://www.bitcongress.com/pepcon2017/
Drug Discovery 2017
27 March 2017 - 28 March 2017
Drug Discovery 2017 aims to bridge the gaps in approval for drug discovery and development by discussing the latest scientific breakthroughs, exploring novel technologies and approaches that can be used to overcome drug development challenges. The event will bring togehter industry leaders who will highlight future opportunities for novel therapeutic discovery. Some of our featured speakers include
• Lorenz Mayr, VP & Global Head, AstraZeneca
• Guido Hanaeur, Scientific Director Translational Medicine, Takeda
• Ulrich Schopfer, Executive Director, Head Integrated Lead Discovery, Novartis
• Yolanda Chong, Principal Scientist, Johnson & Johnson
• Matthias Frech, Director, Molecular Interactions & Biophysics, Merck Serono
• Wengard Czechtizky, Head of Chemistry, Sanofi
• Ulrich Schopfer, Executive Director, head Integrated Lead Discovery, Novartis
• Stephen Pickett, Senior Scientific Investigator, GSK
Plus more from AbbVie, UCB Pharma, Eli Lilly, TissUse, Heptares etc.
Key Highlights:
• AstraZeneca discusses the use of CRISPR/Cas9 Technology in target discovery, hit finding and translational studies
• Novartis optimises the success of phenotyping screening
• Takeda explores whether translational medicine is capable of increasing success rate in pharma
• Gain insights into receptor activation from agonist and antagonist structures with Merck
• Discover applications of enabling chemistry technology to the acceleration of the drug discovery process with AbbVie
Holiday Inn Kensington Forum, London, UK
https://www.smi-online.co.uk/pharmaceuticals/uk/drug-discovery?utm_medium=www.drug-discovery.co.uk&utm_source=P-218&utm_campaign=DDT
5th Annual Pharma Labeling Compliance Conference
29 March 2017 - 30 March 2017
Join 60+ senior-level executives at this exclusive event, for an intimate networking experience. This conference will discuss strategies and insights needed to develop innovative ways to utilize human factors and usability data represented in the product label, mastering combination product labeling, and strategies to document core content. Hear from Sanofi, AbbVie, Inc., Genetech, Inc., Shire, Eisai, Inc., and more!
Boston, MA, USA
https://goo.gl/SQEmLF
Asthma & COPD 2017
29 March 2017 - 30 March 2017
Aimed at senior scientists and respiratory and inhalation specialists, Asthma & COPD 2017 will reflect on the ongoing issues and latest developments of these two diseases.
With a carefully selected panel of industry experts, the 2017 event will address the latest challenges and changes in the fields of asthma and COPD. The agenda will explore novel approaches to treatment, including cutting edge developments in triple combination therapies and phenotyping. As well as identify challenges to device development and delivery, deepen our understanding of the problems relating to these diseases, and discuss the hot topic of electronic health monitoring.
Hear from MHRA, Mylan, AstraZeneca, Teva UK, GlaxoSmithKline, Boehringer Ingelheim, Glenmark Pharmaceuticals, Janssen, AstraZeneca, Novartis and many more…
Early birds available
Holiday Inn Kensington Forum, London, UK
https://www.smi-online.co.uk/pharmaceuticals/uk/asthma-copd?utm_medium=www.asthma-copd.co.uk&utm_source=P-200&utm_campaign=drugdiscoverytoday